Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4, Prospective, Randomized Study Comparing 14-day Non-bismuth Quadruple "Hybrid" and "Concomitant" Therapies for Helicobacter Pylori Eradication in Settings With High Clarithromycin Resistance

NCT01464060 is registered in ClinicalTrials.gov with Infante, Javier Molina, M.D. as lead sponsor.

NCT NCT01464060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01464060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4, Prospective, Randomized Study Comparing 14-day Non-bismuth Quadruple "Hybrid" and "Concomitant" Therapies for Helicobacter Pylori Eradication in Settings With High Clarithromycin Resistance
Lead sponsor
Infante, Javier Molina, M.D.
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2011
Completion date
January 31, 2013
Enrollment
400 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection